| # | Drug | Count |
|---|---|---|
| 0 | PACLITAXEL | 233 |
| 1 | PACLITAXEL (AIBUMIN-BOUND) | 209 |
| 2 | RANIBIZUMAB | 176 |
| 3 | BEVACIZUMAB | 153 |
| 4 | DEXAMETHASONE | 94 |
| 5 | ADALIMUMAB | 93 |
| 6 | PREDNISONE | 92 |
| 7 | METHOTREXATE SODIUM | 85 |
| 8 | FINGOLIMOD HCL | 81 |
| 9 | METHOTREXATE | 77 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRAVOPROST INTRACAMERAL | 12 | 0.1017 |
| 1 | OMIDENEPAG ISOPROPYL | 5 | 0.0758 |
| 2 | COBALT | 1 | 0.0256 |
| 3 | ACETYLCHOLINE CHLORIDE | 2 | 0.0204 |
| 4 | ESTRADIOL VALERATE | 15 | 0.0193 |
| 5 | NEPAFENAC | 58 | 0.0182 |
| 6 | VERTEPORFIN FOR INJECTION | 25 | 0.0169 |
| 7 | TROPICAMIDE | 25 | 0.0153 |
| 8 | MOEXIPRIL HYDROCHLORIDE | 1 | 0.0149 |
| 9 | CEFUROXIME SODIUM | 18 | 0.0147 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 314 |
| 1 | Corticosteroid [EPC] | 292 |
| 2 | Microtubule Inhibitor [EPC] | 269 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 138 |
| 4 | Prostaglandin Analog [EPC] | 123 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 89 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 78 |
| 7 | Kinase Inhibitor [EPC] | 70 |
| 8 | Platinum-based Drug [EPC] | 57 |
| 9 | Aromatase Inhibitor [EPC] | 56 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cyclooxygenase Inhibitor [EPC] | 1 | 0.0122 |
| 1 | Photoenhancer [EPC] | 25 | 0.0064 |
| 2 | alpha-1 Adrenergic Agonist [EPC] | 18 | 0.0041 |
| 3 | Antihypoglycemic Agent [EPC] | 17 | 0.0040 |
| 4 | Antiseptic [EPC] | 16 | 0.0037 |
| 5 | Chemokine Receptor Type 4 Interaction [EPC] | 4 | 0.0029 |
| 6 | CD22-directed Immunoconjugate [EPC] | 6 | 0.0020 |
| 7 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 26 | 0.0019 |
| 8 | Anticholinergic [EPC] | 29 | 0.0018 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 314 | 0.0017 |